中华器官移植杂志
中華器官移植雜誌
중화기관이식잡지
CHINESE JOURNAL OF ORGAN TRANSPLANTATION
2013年
11期
655-657
,共3页
徐健%杜传福%苗芸%余玉明%叶俊生%于立新
徐健%杜傳福%苗蕓%餘玉明%葉俊生%于立新
서건%두전복%묘예%여옥명%협준생%우립신
肾移植%急性排斥反应%CD39%免疫调节
腎移植%急性排斥反應%CD39%免疫調節
신이식%급성배척반응%CD39%면역조절
Kidney transplantation%Acute rejection%CD39%Immunoregulation
目的 探讨肾移植受者外周血中CD39+调节性T淋巴细胞(Treg细胞)的表达及其免疫调节作用.方法 接受首次肾移植的受者30例,术后28 d内14例发生急性排斥反应(AR组),16例未发生急性排斥反应(NR组).所有受者术后采用他克莫司+吗替麦考酚酯+泼尼松的三联免疫抑制方案.以健康志愿者12例为对照组.采集受者和志愿者外周血,经密度离心法分离单个核细胞.采用流式细胞术分选CD4+CD25-反应性T淋巴细胞(Tresp细胞)、CD39-Treg细胞和CD39+Treg细胞.检测CD39+ Treg与CD4+T淋巴细胞的比值,采用酶联免疫吸附试验法检测CD39+Treg细胞对Tresp细胞分泌γ干扰素(IFN-γ)和白细胞介素17(IL-17)的抑制作用.结果 AR组CD39+ Treg细胞与CD4+T淋巴细胞的比值为(1.1±0.5)%,明显低于对照组的(1.8±0.6)%和NR组的(2.1±0.7)%(P<0.05).对照组和NR组CD39+ Treg细胞可显著抑制Tresp细胞分泌IFN-γ和IL-17(P<0.05),CD39-Treg可抑制IFN-γ的分泌(P<0.05),但对IL-17的分泌无抑制作用.NR组CD39+ Treg可抑制IFN-γ的分泌(P<0.05),但对IL-17的分泌无抑制作用.结论 CD39+ Treg细胞具有重要的免疫调节功能;肾移植后急性排斥反应发生时,外周血CD39+ Treg数量减少,且部分抑制功能受损.
目的 探討腎移植受者外週血中CD39+調節性T淋巴細胞(Treg細胞)的錶達及其免疫調節作用.方法 接受首次腎移植的受者30例,術後28 d內14例髮生急性排斥反應(AR組),16例未髮生急性排斥反應(NR組).所有受者術後採用他剋莫司+嗎替麥攷酚酯+潑尼鬆的三聯免疫抑製方案.以健康誌願者12例為對照組.採集受者和誌願者外週血,經密度離心法分離單箇覈細胞.採用流式細胞術分選CD4+CD25-反應性T淋巴細胞(Tresp細胞)、CD39-Treg細胞和CD39+Treg細胞.檢測CD39+ Treg與CD4+T淋巴細胞的比值,採用酶聯免疫吸附試驗法檢測CD39+Treg細胞對Tresp細胞分泌γ榦擾素(IFN-γ)和白細胞介素17(IL-17)的抑製作用.結果 AR組CD39+ Treg細胞與CD4+T淋巴細胞的比值為(1.1±0.5)%,明顯低于對照組的(1.8±0.6)%和NR組的(2.1±0.7)%(P<0.05).對照組和NR組CD39+ Treg細胞可顯著抑製Tresp細胞分泌IFN-γ和IL-17(P<0.05),CD39-Treg可抑製IFN-γ的分泌(P<0.05),但對IL-17的分泌無抑製作用.NR組CD39+ Treg可抑製IFN-γ的分泌(P<0.05),但對IL-17的分泌無抑製作用.結論 CD39+ Treg細胞具有重要的免疫調節功能;腎移植後急性排斥反應髮生時,外週血CD39+ Treg數量減少,且部分抑製功能受損.
목적 탐토신이식수자외주혈중CD39+조절성T림파세포(Treg세포)적표체급기면역조절작용.방법 접수수차신이식적수자30례,술후28 d내14례발생급성배척반응(AR조),16례미발생급성배척반응(NR조).소유수자술후채용타극막사+마체맥고분지+발니송적삼련면역억제방안.이건강지원자12례위대조조.채집수자화지원자외주혈,경밀도리심법분리단개핵세포.채용류식세포술분선CD4+CD25-반응성T림파세포(Tresp세포)、CD39-Treg세포화CD39+Treg세포.검측CD39+ Treg여CD4+T림파세포적비치,채용매련면역흡부시험법검측CD39+Treg세포대Tresp세포분비γ간우소(IFN-γ)화백세포개소17(IL-17)적억제작용.결과 AR조CD39+ Treg세포여CD4+T림파세포적비치위(1.1±0.5)%,명현저우대조조적(1.8±0.6)%화NR조적(2.1±0.7)%(P<0.05).대조조화NR조CD39+ Treg세포가현저억제Tresp세포분비IFN-γ화IL-17(P<0.05),CD39-Treg가억제IFN-γ적분비(P<0.05),단대IL-17적분비무억제작용.NR조CD39+ Treg가억제IFN-γ적분비(P<0.05),단대IL-17적분비무억제작용.결론 CD39+ Treg세포구유중요적면역조절공능;신이식후급성배척반응발생시,외주혈CD39+ Treg수량감소,차부분억제공능수손.
Objective To investigate expression and suppressive function of CD39 + regulatory T cells (Treg) in kidney transplant recipients.Method Thirty recipients of first kidney transplants were treated with tacrolimus,mycophenolate mofetil and prednisone.Within 28 days posttransplantation,there were 14 patients subject to acute rejection (AR group),and the rest 16 patients had no episodes of acute rejections (NR group).Twelve healthy volunteers served as healthy controls (HC group).We collected peripheral blood from the three groups and separated PBMC by density gradient centrifugation,and sorted Tresp,CD39-Treg and CD39+ Treg by flow cytometry.We next analyzed the ratio of CD39 + Treg/CD4+ T cells.ELISA was used to determine the suppressive ability of CD39-Treg and CD39+ Treg on secretion of IFN-γ and IL-17 by Tresp.Results The ratio of CD39 + Treg/CD4 + T cells in AR group was significantly reduced as compared with HC group and NR group (P<0.05).In HC group and NR group,the secretion of IFN-γ and IL-17 by Tresp was suppressed significantly (P<0.05) by CD39+ Treg.CD39Treg could suppress secretion of IFN-γ but not IL-17 production by Tresp.CD39+ Treg in AR group AR could suppress the secretion of IFN-γ significantly (P<0.01),but not to IL-17 production.Conclusion CD39+ Treg have important immunoregulation function.The relative amount of CD39+ Treg was reduced and their regulatory function was impaired in patients with acute rejection.